These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma. Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546 [TBL] [Abstract][Full Text] [Related]
64. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis. Ljungberg B Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340 [TBL] [Abstract][Full Text] [Related]
65. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate. Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701 [TBL] [Abstract][Full Text] [Related]
66. Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin-embedded specimens. Frierson HF Hum Pathol; 1988 Mar; 19(3):290-4. PubMed ID: 2450060 [TBL] [Abstract][Full Text] [Related]
67. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573 [TBL] [Abstract][Full Text] [Related]
68. [Renal cell carcinoma: DNA cytometry and its clinical significance. An 8 year survival study]. al-Abadi H; Nagel R Helv Chir Acta; 1991 Sep; 58(3):331-4. PubMed ID: 1769855 [TBL] [Abstract][Full Text] [Related]
69. Relationship between DNA ploidy, antigen expression and survival in renal cell carcinoma. Oosterwijk E; Warnaar SO; Zwartendijk J; van der Velde EA; Fleuren GJ; Cornelisse CJ Int J Cancer; 1988 Nov; 42(5):703-8. PubMed ID: 3182107 [TBL] [Abstract][Full Text] [Related]
70. Flow cytometric DNA ploidy analysis in canine transitional cell carcinoma of urinary bladders. Clemo FA; DeNicola DB; Carlton WW; Morrison WB; Walker E Vet Pathol; 1994 Mar; 31(2):207-15. PubMed ID: 8203084 [TBL] [Abstract][Full Text] [Related]
71. Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses. Brunelli M; Delahunt B; Gobbo S; Tardanico R; Eccher A; Bersani S; Cossu-Rocca P; Parolini C; Balzarini P; Menestrina F; Cheng L; Eble JN; Martignoni G Am J Clin Pathol; 2010 Jan; 133(1):116-26. PubMed ID: 20023267 [TBL] [Abstract][Full Text] [Related]
72. Flow cytometric analysis of primary and metastatic squamous cell carcinoma of the oral cavity and oropharynx. Syms CA; Eibling DE; McCoy JP; Barnes L; Emanuel B; Fowler C; Wagner R; Johnson JT Laryngoscope; 1995 Feb; 105(2):149-55. PubMed ID: 8544594 [TBL] [Abstract][Full Text] [Related]
73. Deoxyribonucleic acid ploidy and cell cycle analysis of colorectal carcinoma by flow cytometry. A prospective study of 137 cases using fresh whole cell suspensions. Hood DL; Petras RE; Edinger M; Fazio V; Tubbs RR Am J Clin Pathol; 1990 May; 93(5):615-20. PubMed ID: 2327364 [TBL] [Abstract][Full Text] [Related]
74. Clinical and flow cytometric analyses of renal cell carcinomas with reference to incidental or non-incidental detection. Sasaki Y; Homma Y; Hosaka Y; Tajima A; Aso Y Jpn J Clin Oncol; 1994 Feb; 24(1):32-6. PubMed ID: 8126918 [TBL] [Abstract][Full Text] [Related]
75. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08. Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703 [TBL] [Abstract][Full Text] [Related]
76. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma. Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763 [TBL] [Abstract][Full Text] [Related]
77. [Flow cytometric DNA analysis in colorectal cancer]. Ando Y; Tsuchiya A; Sekikawa K; Ishii Y; Yoshida T; Kimijima I; Abe R Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1571-5. PubMed ID: 2586468 [TBL] [Abstract][Full Text] [Related]
78. Quantitative DNA analysis in renal cell carcinoma. Comparison of flow and image cytometry. Papadopoulos I; Weichert-Jacobsen K; Nürnberg N; Sprenger E Anal Quant Cytol Histol; 1995 Aug; 17(4):272-5. PubMed ID: 8526952 [TBL] [Abstract][Full Text] [Related]
79. Flow cytometric nuclear DNA content of fresh and paraffin-embedded tissues of breast carcinomas and fibroadenomas. De Vita R; Calugi A; Eleuteri P; Maggi O; Nassuato C; Vecchione A Eur J Basic Appl Histochem; 1991; 35(3):233-44. PubMed ID: 1718443 [TBL] [Abstract][Full Text] [Related]
80. [Clinical application of flow cytometry in urology. 4. The role of the flow cytometric DNA-histogram as a prognostic factor of renal cell carcinomas]. Tachibana M; Jitsukawa S; Nakajima J; Iigawa T; Deguchi N; Baba S; Nakazono M; Hata M; Tazaki H Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):816-21. PubMed ID: 3694979 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]